Journal of the International AIDS Society (Jul 2024)

Cervical cancer prevention and care in HIV clinics across sub‐Saharan Africa: results of a facility‐based survey

  • Serra Lem Asangbeh‐Kerman,
  • Maša Davidović,
  • Katayoun Taghavi,
  • Tafadzwa Dhokotera,
  • Albert Manasyan,
  • Anjali Sharma,
  • Antoine Jaquet,
  • Beverly Musick,
  • Christella Twizere,
  • Cleophas Chimbetete,
  • Gad Murenzi,
  • Hannock Tweya,
  • Josephine Muhairwe,
  • Kara Wools‐Kaloustian,
  • Karl‐Gunter Technau,
  • Kathryn Anastos,
  • Marcel Yotebieng,
  • Marielle Jousse,
  • Oliver Ezechi,
  • Omenge Orang'o,
  • Samuel Bosomprah,
  • Simon Pierre Boni,
  • Partha Basu,
  • Julia Bohlius,
  • IeDEA

DOI
https://doi.org/10.1002/jia2.26303
Journal volume & issue
Vol. 27, no. 7
pp. n/a – n/a

Abstract

Read online

Abstract INTRODUCTION To eliminate cervical cancer (CC), access to and quality of prevention and care services must be monitored, particularly for women living with HIV (WLHIV). We assessed implementation practices in HIV clinics across sub‐Saharan Africa (SSA) to identify gaps in the care cascade and used aggregated patient data to populate cascades for WLHIV attending HIV clinics. METHODS Our facility‐based survey was administered between November 2020 and July 2021 in 30 HIV clinics across SSA that participate in the International epidemiology Databases to Evaluate AIDS (IeDEA) consortium. We performed a qualitative site‐level assessment of CC prevention and care services and analysed data from routine care of WLHIV in SSA. RESULTS Human papillomavirus (HPV) vaccination was offered in 33% of sites. Referral for CC diagnosis (42%) and treatment (70%) was common, but not free at about 50% of sites. Most sites had electronic health information systems (90%), but data to inform indicators to monitor global targets for CC elimination in WLHIV were not routinely collected in these sites. Data were collected routinely in only 36% of sites that offered HPV vaccination, 33% of sites that offered cervical screening and 20% of sites that offered pre‐cancer and CC treatment. CONCLUSIONS Though CC prevention and care services have long been available in some HIV clinics across SSA, patient and programme monitoring need to be improved. Countries should consider leveraging their existing health information systems and use monitoring tools provided by the World Health Organization to improve CC prevention programmes and access, and to track their progress towards the goal of eliminating CC.

Keywords